Medicines360 is a 501(c)(3) organization based in San Francisco, California, registered in 2009, with $14,759,061 in FY2024 revenue. CharityIndex grades it B, and it directs about 72% of spending to programs.
Revenue (FY2024)
$14.8M
▲ 47.5% vs prior year
Medical Research median: $217K
Expenses (FY2024)
$15.8M
Net assets
$48.0M
Employees
33
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Medicines360: 72% to programs · $19 to raise $100 earns a C on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Medicines360: 36 mo reserves · -7% margin earns a B+ on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Medicines360: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Medicines360: 4 of 5 disclosure signals earns a A on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Medicines360 is a non-profit women's health organization that focuses on developing new products and accelerating access to innovation for women.
Revenue grew from $2.0M (FY2013) to $14.8M (FY2024) across 12 reported years.
Financial snapshot
Operating margin
-7.3%
Spent more than it raised in the latest fiscal year.
Total assets
$52.0M
Total liabilities
$4.0M
Net assets
$48.0M
Salaries & benefits
$8.5M
54% of expenses
Board members
7
6 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $14,759,061▲47.5% | $15,830,980▼18.1% | $47,963,246▲2.4% | $51,961,979▼0.1% | 990 |
| 2023 | $10,006,742▼8.5% | $19,326,497▲3.1% | $46,832,301▼20.9% | $51,992,405▼20.0% | 990 |
| 2022 | $10,933,921▼55.7% | $18,738,779▼17.0% | $59,240,788▼20.1% | $65,028,349▼16.8% | 990 |
| 2021 | $24,675,342▲105% | $22,588,940▼3.2% | $74,112,810▼8.0% | $78,136,858▼7.4% | 990 |
| 2020 | $12,024,199▼30.9% | $23,337,557▼2.0% | $80,555,133▼6.5% | $84,365,229▼5.9% | 990 |
| 2019 | $17,400,453▲4.3% | $23,813,287▲11.5% | $86,132,959▲46.1% | $89,670,482▲3.0% | 990 |
| 2018 | $16,684,261▼28.5% | $21,355,992▲25.4% | $58,962,989▼14.0% | $87,075,006▼11.6% | 990 |
| 2017 | $23,326,051▲204% | $17,034,239▲2.8% | $68,565,348▲17.0% | $98,482,629▲7.1% | 990 |
| 2016 | $7,672,651▼89.0% | $16,564,862▲4.2% | $58,582,770▼14.4% | $91,943,412▼12.2% | 990 |
| 2015 | $69,492,345▲2115% | $15,893,825▲101% | $68,423,003▲360% | $104,754,032▲102% | 990 |
| 2014 | $3,137,921▲53.7% | $7,910,891▼35.5% | $14,875,920▼24.5% | $51,980,781▼15.1% | 990 |
| 2013 | $2,041,551 | $12,266,842▼21.3% | $19,696,321▼34.3% | $61,196,816▲91.4% | 990 |
| 2012 | — | $15,595,390▲26.3% | $29,988,948▼1.7% | $31,969,127▲0.8% | 990 |
| 2011 | — | $12,349,532▲31.5% | $30,498,733▲30.7% | $31,712,179▲32.5% | 990 |
| 2010 | — | $9,391,809 | $23,328,789 | $23,926,803 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Andrea Olariu — $771,904 (4.88% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Andrea Olariu | Ceo | 40 | $771,904 |
| Bradley Luke | Chief Financial Officer | 40 | $519,704 |
| Cynthia Hu | General Counsel/bod Sec (to 6/2024) | 37.81 | $499,660 |
| Autumn Ehnow | Evp, Corporate Affairs | 40 | $423,485 |
| Robert Deckman | Vp, Product Development & Sustain Eng | 40 | $400,501 |
| Mark Busch | Svp, Quality Assurance & Product Safety | 37.74 | $398,963 |
| Margot Fahnestock | Vp, Strategic Development | 37.81 | $355,845 |
| Natalie Otten | Vp, Finance & Accounting | 35.66 | $354,739 |
| Lisa David | Bod Chair | 2 | $60,000 |
| Ann Barber | Director | 2 | $40,000 |
| Elizabeth Garner | Director | 2 | $40,000 |
| Karen Dawes | Director | 2 | $40,000 |
| Mike Dorsey | Director | 2 | $40,000 |
| Erica Rogers | Director (from 6/2024 To 12/2024) | 2 | $30,000 |
| Leslie Benet | Director (to 6/2024) | 2 | $20,000 |
| Contractor | Services | Paid |
|---|---|---|
| Poba Medical Inc | Consultant Services | $571,684 |
| Polyvation Bv | Consultant Services | $285,000 |
| Bapna Consulting Corporation | Consultant Services | $195,153 |
| Veeva Systems Inc | Cloud-based Software | $170,936 |
| Buchlater | Legal Services | $166,875 |
3 grants to Medicines360 totaling $280K, reported by foundations on their Schedule I filings.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Family Health International | Global health | 2021 | $60,000 |
| Family Health International | Global health research | 2019 | $20,000 |
| Hopewell Fund | Civil rights, social action, advocacy | 2018 | $200,000 |
1 grant totaling $8,000 in FY2021. All grants made by Medicines360 →
| Recipient | Purpose | Amount |
|---|---|---|
| Regents of the University of California | Bring together a small group of experts to address bleeding reporting guidelines for sarc and larc | $8,000 |
Explore more
Data for Medicines360 (EIN 26-4443340) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.